AUS
NZ
UK
CA
USA
IND
Healthcare
Four ASX healthcare stocks with over 90% gains in past 52 weeks
September 18, 2022 10:00 AM AEST| By Aditi SarkarNEU, AVR, NTI and CTE are some of the ASX-listed healthcare stocks with over 90% price returns in the last 52 weeks.
How are CSL (ASX:CSL) shares performing on YTD basis?
September 16, 2022 11:02 AM AEST| By Sonal GoyalShares of CSL Limited (ASX:CSL) opened in red today despite no price-sensitive news released by the group.
ASX-listed healthcare giants in focus today
September 13, 2022 04:51 PM AEST| By RitwikaThe health care sector was the worst performing sector on ASX today. Let us see how the ASX-listed healthcare companies are faring today.
Ramsay (ASX:RHC) ends talks on IHH's acquisition proposal
September 09, 2022 11:01 AM AEST| By RitwikaRamsay concludes all discussion on IHH's proposed acquisition.
Healthia (ASX:HLA) calls for a trading halt today, here’s why
September 08, 2022 11:01 AM AEST| By RitwikaKnow why Healthia puts its securities under trading halt until Monday.
_09_07_2022_01_07_19_102809.jpg){kind=logo}
How are CSL (ASX:CSL) shares performing on ASX?
September 07, 2022 11:04 AM AEST| By Sonal GoyalShares of CSL Limited (ASX:CSL) have dropped by 0.31% per share today despite no price-sensitive news released by the group.
AFT Pharma (ASX:AFP) to initiate further studies on Maxigesic IV
September 02, 2022 11:59 AM AEST| By RitwikaAFT Pharmaceuticals will conduct additional studies related to Maxigesic IV's packaging before filing for the US FDA registration.
_07_07_2022_05_54_58_776933_09_01_2022_02_05_51_605187.png)
Kalkine : Fisher & Paykel (ASX:FPH) to buy land in Auckland for AU$275M
September 01, 2022 12:01 PM AEST| By Bhawna GuptaFisher & Paykel has signed an agreement to buy a second New Zealand campus.
From JTL, to SHG, AYA: How are these healthtech stocks faring on ASX?
August 31, 2022 04:31 PM AEST| By Aditi SarkarJTL, OAK, GLH, SHG, and AYA are ASX-listed health tech stocks that were on investor’s radar in August.
Mesoblast’s (ASX:MSB) net loss falls to US$91.3M in FY22
August 31, 2022 10:59 AM AEST| By Sonal GoyalShare price of Mesoblast Limited (ASX:MSB) marked a gain after the company reported a fall in loss after tax.
Ramsay (ASX:RHC) records rise in FY22 revenues; requests trading halt
August 26, 2022 11:02 AM AEST| By Bhawna GuptaRamsay reported total revenues of AU$13,740 million, a 3.1% rise over the previous corresponding period (pcp).
Up 19% in five days, what’s driving Invex’s (ASX:IXC) share price?
August 23, 2022 01:21 PM AEST| By Sonal Goyalshares of Invex registered a gain of 15% in last five trading session following an update released by the company on ASX.
OCC, PSQ, SDI : Take a look at performance of these ASX dental stocks
August 23, 2022 11:36 AM AEST| By Aditi SarkarDental services were impacted by COVID-19 and recently, the ongoing inflation might have led people to defer dental services Orthocell, Pacific Smiles, SDI Limited are three ASX-listed dental stocks that cater to dental services.
Why Cochlear’s (ASX:COH) shares would be closely tracked today
August 19, 2022 09:13 AM AEST| By AshishCochlear (ASX:COH) on Friday reported a rise in sales revenue in FY22, buoyed by driven by robust demand for acoustic implants
From FPH, RMD to COH: How are these healthcare giants faring on ASX
August 18, 2022 06:32 PM AEST| By RitwikaToday the health care sector performed well and became one of the three best performing sectors on the ASX today.
What weighed on CSL’s (ASX:CSL) profit in FY22
August 17, 2022 09:18 AM AEST| By AshishCSL Ltd (ASX:CSL) on Wednesday announced a fall in profit in the financial year 2022 due to challenges posed by COVID-19 pandemic.
_08_12_2022_01_53_19_717202.jpg){kind=logo}
ResMed (ASX:RMD) lifts quarterly dividend, here’s how shares are reacting?
August 12, 2022 11:49 AM AEST| By Sonal GoyalShares of ResMed has dropped despite sharing positive quarterly results and increase in dividend.
CSL completes Vifor Pharma acquisition; here’s how shares are faring on ASX
August 10, 2022 12:34 PM AEST| By RitwikaCSL Limited finally completed the Vifor Pharma acquisition on 9 August 2022.
_08_09_2022_06_58_25_850746.jpg){kind=logo}
How are CSL shares performing after finalisation of Vifor acquisition?
August 09, 2022 04:56 PM AEST| By Sonal GoyalShares of CSL Limited (ASX:CSL) gained almost 1% on the ASX today although no price sensitive news came from the company’s camp today.
Here’s why Mesoblast (ASX:MSB) has suspended trading today
August 08, 2022 03:59 PM AEST| By RitwikaMesoblast shares went under a voluntary suspension on the ASX today. Trading is expected to commence after the company releases its capital raising announcement on 10 August 2022.
Advertise your brand on Kalkine Media